Novo Nordisk's Strategic Moves in Weight-Loss Market Shakeup
Published on: Jan. 6, 2026, 2:29 a.m. | Source: Devdiscourse
Danish drugmaker Novo Nordisk introduces its Wegovy weight-loss pill in the US amidst a competitive drug market. The FDA's recent approval boosts Novo's position against Eli Lilly, with pricing concerns looming. Other health updates include flu season severity, MPM BioImpact's IPO plans, and growing legal scrutiny of abortion pills.
